Characteristics of University students using stimulants for cognitive enhancement: A pilot study;Charakteristika von Studierenden, die Pharmakologisches Neuroenhancement mit Stimulanzien betreiben: Eine Pilotstudie

Psychiatrische Praxis

Volumn 39, Issue 4, 2012, Pages 174-180

  Franke, Andreasg ^a   Schwarze, Corneliae ^a   Christmann, Michaela ^a   Bonertz, Caroline ^a   Hildt, Elisabeth ^b   Lieb, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

addiction; cognitive enhancement; misuse; pharmacological neuroenhancement; stimulants

Indexed keywords

AMPHETAMINE DERIVATIVE; CENTRAL NERVOUS SYSTEM AGENTS; METHYLPHENIDATE; PHARMACOLOGICAL NEUROENHANCEMENT; UNCLASSIFIED DRUG;

ADDICTION; ARTICLE; COGNITION; CONTROLLED STUDY; HUMAN; PILOT STUDY; SEMI STRUCTURED INTERVIEW; SUBSTANCE ABUSE; UNIVERSITY STUDENT;

ADOLESCENT; ADULT; ALCOHOLISM; AMPHETAMINES; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; COMORBIDITY; DRUG UTILIZATION; FEMALE; GERMANY; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MARIJUANA ABUSE; METHYLPHENIDATE; NOOTROPIC AGENTS; PILOT PROJECTS; STREET DRUGS; STUDENTS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84860609456     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0031-1298900     Document Type: Article

References (29)

1. Franke AG, Lieb K. Missbrauch von Psychopharmaka zum Hirndoping. CME-Artikel. InFo Neurologie & Psychiatrie: 2009; 11 42 51
2. Lieb K. Hirndoping - Warum wir nicht alles schlucken sollen. Düsseldorf Artemis & Winkler: 2010
3. Franke AG, Christmann M, Bonertz C et al. Use of Coffee, Caffeinated Drinks and Caffeine Tablets for Cognitive Enhancement in Pupils and Students in Germany. Pharmacopsychiatry: 2011; 44 331 338
4. Franke AG, Bonertz C, Christmann M et al. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry: 2011; 44 60 66
5. Franke AG, Lieb K. Pharmacological neuroenhancement and brain doping: Chances and risks. Bundesgesundheitsbl Gesundheitsf Gesundheitsschutz: 2010; 53 853 859
6. Wilens TE, Adler LA, Adams J et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry: 2008; 47 21 31
7. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health: 2000; 49 143 145
8. McCabe SE, Knight JR, Teter CJ et al. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction: 2005; 100 96 106
9. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse: 2004; 39 1095 1116 (Pubitemid 39163121)
10. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs: 2006; 38 43 56
11. Teter CJ, McCabe SE, Boyd CJ et al. Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors. Pharmacotherapy: 2003; 23 609 617 (Pubitemid 36546192)
12. Kaloyanides KB, McCabe SE, Cranford JA et al. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy: 2007; 27 666 674 (Pubitemid 46700958)
13. Upadhyaya HP, Rose K, Wang W et al. Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol: 2005; 15 799 809 (Pubitemid 41567151)
14. Teter CJ, McCabe SE, Cranford JA et al. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health: 2005; 53 253 262 (Pubitemid 40720541)
15. Teter CJ, McCabe SE, LaGrange K et al. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy: 2006; 26 1501 1510 (Pubitemid 44521735)
16. Wilens TE, Gignac M, Swezey A et al. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. J Am Acad Child Adolesc Psychiatry: 2006; 45 408 414 (Pubitemid 43675545)
17. Barrett SP, Darredeau C, Bordy LE et al. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry: 2005; 50 457 461 (Pubitemid 43161798)
18. Wittchen HU, Zandig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV. Göttingen Hogrefe: 1997
19. First MB, Gibbon M, Spitzer RL, Williams JBW. Users Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington DC American Psychiatric Press: 1997
20. First MB, Gibbon M, Spitzer RL, Williams JBW. Users Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington DC American Psychiatric Press: 1997
21. Krampen G. Fragebogen zu Kompetenz- und Kontrollüberzeugungen (FKK) - Handanweisung. Göttingen Hogrefe: 1991
22. Rheinberg F. Motivationsdiagnostik. Kompendium psychologische Diagnostik. Band 5. Göttingen Hogrefe: 2004
23. White BP, Becker-Blease KA, Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. J Am Coll Health: 2006; 54 261 268
24. McCabe SE, Boyd CJ. Sources of prescription drugs for illicit use. Addict Behav: 2005; 30 1342 1350 (Pubitemid 40967022)
25. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction: 2007; 102 740 751 (Pubitemid 46633355)
26. Kroutil LA, Van Brunt DL, Herman-Stahl MA et al. Nonmedical use of prescription stimulants in the United States. Drug Alcohol Depend: 2006; 84 135 143 (Pubitemid 44160579)
27. Sulzer D, Sonders MS, Poulsen NW et al. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol: 2005; 75 406 433 (Pubitemid 40834286)
28. Seeman P, Madras BK. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry: 1998; 3 386 396 (Pubitemid 28442411)
29. Carboni E, Silvagni A. Experimental investigations on dopamine transmission can provide clues on the mechanism of the therapeutic effect of amphetamine and methylphenidate in ADHD. Neural Plast: 2004; 11 77 95 (Pubitemid 39089573)